Daoming Optics&Chemical Co.,Ltd
SZSE:002632.SZ
6.93 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,322.707 | 1,286.599 | 1,283.794 | 1,266.46 | 1,391.642 | 1,197.355 | 806.798 | 521.792 | 429.498 | 462.778 | 406.25 | 362.504 | 408.108 | 327.147 | 228.417 | 250.179 |
Cost of Revenue
| 877.492 | 893.69 | 803.458 | 778.551 | 864.898 | 749.367 | 495.543 | 346.052 | 291.117 | 329.406 | 280.459 | 253.949 | 266.102 | 213.305 | 155.92 | 193.771 |
Gross Profit
| 445.215 | 392.909 | 480.336 | 487.909 | 526.743 | 447.988 | 311.256 | 175.74 | 138.381 | 133.372 | 125.791 | 108.555 | 142.007 | 113.842 | 72.497 | 56.408 |
Gross Profit Ratio
| 0.337 | 0.305 | 0.374 | 0.385 | 0.379 | 0.374 | 0.386 | 0.337 | 0.322 | 0.288 | 0.31 | 0.299 | 0.348 | 0.348 | 0.317 | 0.225 |
Reseach & Development Expenses
| 68.249 | 63.372 | 70.763 | 52.393 | 61.385 | 42.993 | 33.198 | 24.487 | 18.169 | 25.892 | 23.564 | 12.268 | 12.601 | 10.323 | 6.912 | 6.481 |
General & Administrative Expenses
| 35.782 | 34.658 | 32.79 | 26.53 | 34.043 | 33.857 | 23.053 | 21.248 | 11.208 | 13.066 | 14.887 | 13.681 | 7.835 | 26.061 | 4.534 | 4.854 |
Selling & Marketing Expenses
| 64.588 | 63.16 | 76.262 | 79.772 | 82.37 | 73.047 | 47.445 | 32.851 | 24.773 | 25.385 | 27.825 | 27.266 | 19.752 | 16.673 | 10.296 | 9.02 |
SG&A
| 100.37 | 97.818 | 109.052 | 106.302 | 116.413 | 106.904 | 70.498 | 54.099 | 35.98 | 38.451 | 42.712 | 40.947 | 27.587 | 42.734 | 14.83 | 13.874 |
Other Expenses
| 3.425 | 55.159 | 46.884 | 38.184 | 55.772 | -13.643 | -2.829 | 15.573 | 10.11 | 3.673 | 4.507 | 1.709 | 5.409 | 2.112 | 1.768 | -0.022 |
Operating Expenses
| 235.174 | 216.348 | 226.699 | 196.879 | 233.57 | 185.347 | 132.077 | 123.164 | 92.304 | 100.599 | 100.781 | 72.184 | 55.247 | 64.049 | 28.398 | 25.534 |
Operating Income
| 190.323 | 414.408 | 240.741 | 201.222 | 336.229 | 256.924 | 152.524 | 44.474 | 46.192 | 26.116 | 18.236 | 43.031 | 80.095 | 44.171 | 38.698 | 25.851 |
Operating Income Ratio
| 0.144 | 0.322 | 0.188 | 0.159 | 0.242 | 0.215 | 0.189 | 0.085 | 0.108 | 0.056 | 0.045 | 0.119 | 0.196 | 0.135 | 0.169 | 0.103 |
Total Other Income Expenses Net
| -16.293 | -11.235 | -159.908 | -2.412 | -104.872 | -10.426 | -29.484 | 7.358 | 8.303 | -2.994 | -2.277 | 8.37 | -1.256 | -3.545 | -3.692 | -5.046 |
Income Before Tax
| 193.748 | 403.172 | 80.834 | 198.81 | 231.357 | 252.215 | 149.695 | 59.933 | 54.379 | 29.78 | 22.733 | 44.74 | 85.504 | 46.248 | 40.406 | 25.829 |
Income Before Tax Ratio
| 0.146 | 0.313 | 0.063 | 0.157 | 0.166 | 0.211 | 0.186 | 0.115 | 0.127 | 0.064 | 0.056 | 0.123 | 0.21 | 0.141 | 0.177 | 0.103 |
Income Tax Expense
| 37.552 | 89.298 | 25.742 | 37.401 | 34.681 | 46.867 | 27.07 | 15.583 | 9.384 | 2.126 | 4.438 | 5.762 | 10.998 | 9.616 | 5.765 | -0.66 |
Net Income
| 156.71 | 313.938 | 54.943 | 169.199 | 198.244 | 205.424 | 123.753 | 48.71 | 44.995 | 27.611 | 18.374 | 38.978 | 74.505 | 36.632 | 34.642 | 26.488 |
Net Income Ratio
| 0.118 | 0.244 | 0.043 | 0.134 | 0.142 | 0.172 | 0.153 | 0.093 | 0.105 | 0.06 | 0.045 | 0.108 | 0.183 | 0.112 | 0.152 | 0.106 |
EPS
| 0.25 | 0.5 | 0.088 | 0.27 | 0.32 | 0.33 | 0.21 | 0.08 | 0.08 | 0.05 | 0.033 | 0.07 | 0.18 | 0.092 | 0.089 | 0.081 |
EPS Diluted
| 0.25 | 0.5 | 0.088 | 0.27 | 0.32 | 0.33 | 0.21 | 0.08 | 0.08 | 0.05 | 0.033 | 0.07 | 0.18 | 0.092 | 0.089 | 0.081 |
EBITDA
| 360.081 | 564.33 | 350.907 | 355.288 | 426.174 | 336.311 | 235.21 | 132.402 | 114.544 | 83.819 | 66.794 | 66.443 | 110.772 | 66.125 | 56.044 | 37.302 |
EBITDA Ratio
| 0.272 | 0.439 | 0.273 | 0.281 | 0.306 | 0.281 | 0.292 | 0.254 | 0.267 | 0.181 | 0.164 | 0.183 | 0.271 | 0.202 | 0.245 | 0.149 |